November 19, 2019

U.S. Supreme Court Rejects Former Pharma CEO’s Appeal Against Seven-Year Prison Sentence

The U.S. Supreme Court has denied Martin Shkreli's appeal request over his 2017 fraud conviction, effectively upholding his seven-year prison sentence.
November 14, 2019

Big Drugmakers Could Lose $1 Trillion In Sales And Still Be Most Profitable Industry

A new analysis of publicly reported financial data has found that large, brand-name drug manufacturers would still be the most profitable industry sector in the United States even with $1 trillion in lower sales.
November 13, 2019

More Than 42,000 Cancer Lawsuits Now Filed Against Bayer Over Roundup Weedkiller

The number of lawsuits filed against Bayer in the United States, alleging its Roundup weedkiller causes cancer, has risen to more than 42,000.
November 11, 2019

Analysis Of 23 Clinical Trials Finds Opioid Drugs Have No Clear Lasting Benefit In Arthritis

A new analysis of 23 clinical trials has found that opioid drugs have no clear lasting benefit in arthritis.
November 1, 2019

Antibiotics: Even Low Use In Children Can Have A Negative Impact On Health

A new study has found that even low use of antibiotics in children can have a negative impact on their health.
October 31, 2019

Study Suggests Taking Acetaminophen In Pregnancy Linked To Higher Risk Of ADHD & Autism

A new study suggests exposure to acetaminophen (paracetamol) in the womb may increase a child's risk for attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder.
October 30, 2019

Two Charities To Pay $6 Million To Resolve U.S. Pharma Kickback Probe

The U.S. Justice Department says that two charities will pay $6 million to resolve claims they operated as pass-throughs for seven pharmaceutical companies to pay kickbacks to Medicare patients using their high-priced medications.
October 23, 2019

Drug Companies Accused In American Opioid Epidemic Reach $260 Million Out-Of-Court Settlement

Hours before the first federal trial over the American opioid epidemic was about to start, four big drug companies reached an out-of-court settlement totaling $260 million.